Dubol, Manon
Stiernman, Louise http://orcid.org/0000-0002-9662-981X
Wikström, Johan
Lanzenberger, Rupert http://orcid.org/0000-0003-4641-9539
Neill Epperson, C.
Sundström-Poromaa, Inger
Bixo, Marie
Comasco, Erika http://orcid.org/0000-0002-2174-2068
Article History
Received: 13 May 2022
Revised: 25 May 2022
Accepted: 31 May 2022
First Online: 15 June 2022
Competing interests
: RL received travel grants and/or conference speaker honoraria within the last 3 years from Bruker BioSpin MR, Heel, and support from Siemens Healthcare regarding clinical research using PET/MR. He is a shareholder of the start-up company BM Health GmbH since 2019. CNE has served on the advisory board of Asarina Pharma and Sage Therapeutics and has received research funding from and served as a consultant and advisory board member for Sage Therapeutics. ISP has served occasionally on advisory boards or acted as invited speaker at scientific meetings for Asarina Pharma, Bayer Health Care, Gedeon Richter, Peptonics, Shire/Takeda, Sandoz, and Lundbeck A/S. MB is a member of the advisory board for Asarina Pharma. All other authors declare that they have no conflict of interest.